Celltrion stock

South Korea’s KT Corp. is set to sell Initech Co., its Kosdaq-listed financial security unit, for 85 billion won ($59.1 million) as the leadin...

South Korea will sharply raise the threshold for listed companies to remain trading on the domestic stock market to facilitate the delisting of fina...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

The Bank of Korea (BOK) said on Wednesday that the foreign investors' net selling in the South Korean stock market was $3.86 billion in December las...

The S&P 500 index just experienced its best two-year streak since the 1997-98 Asian financial crisis, with the hype surrounding artificial intel...

LG Energy Solution Ltd. reported its first quarterly loss in more than three years on Thursday, adding to concerns that the world’s third-larg...

Samsung Electronics Co. flagged weaker-than-expected earnings for the last quarter of last year due to a fall in memory chip prices and soft demand ...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

South Korean pension funds are raising their bets on infrastructure and global stocks, while reducing exposure to the domestic stock market on a dow...

South Korean stocks are expected to bounce back in the new year as their extremely low valuation following investors’ massive sell-offs in 202...

Han Duck-soo, South Korea’s acting president and prime minister, was impeached in Parliament on Friday amid a deepening political crisis batte...

The number of South Koreans investing in cryptocurrencies recently broke past 15 million — about 30% of the country’s population —...

South Korea will raise the limits on forward dollar purchases and expand the foreign exchange swap line between the National Pension Service (NPS) a...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

LG Electronics Inc. will retire 761,000 shares in 2025, or around 0.5% of its outstanding shares, to increase shareholder returns, the South Korean ...

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...

South Korea's government will host an overseas investor relations session to explain the country’s economic conditions and unveil market-boost...

South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

South Korea’s Finance Minister Choi Sang-mok said on Friday that President Yoon Suk Yeol’s failed martial law attempt will have a very l...

South Korean stocks showed clear divergences on Wednesday amid a mixed market outlook as President Yoon Suk Yeol’s martial law declaration, re...

South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...

The National Pension Service (NPS), South Korea’s largest institutional investor, reported a preliminary 9.18% return from investments, equiva...

When OneAsia Partners, a Seoul-based private equity fund operator, revised part of its PEF Havana I’s articles of association on Feb. 14, 2023...

South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...

South Korean pension funds continued their Kospi market buying spree for a fourth straight month in November, notching their largest net purchases o...

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

South Korea’s Young Poong Corp., embroiled in a fierce management control dispute with Korea Zinc Inc., is now the target of an activist fund ...

South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...